Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Polynovo Limited ( (AU:PNV) ) is now available.
JPMorgan Chase & Co. and its affiliates have reduced their voting power in Polynovo Limited from 9.06% to 7.98%, as detailed in a recent notice of change of interests. This adjustment in voting power may influence the company’s shareholder dynamics and could have implications for its governance and decision-making processes.
More about Polynovo Limited
Polynovo Limited operates in the medical technology industry, focusing on the development and commercialization of innovative medical devices. The company’s primary product is NovoSorb, a biodegradable polymer technology used in various medical applications, including wound care and surgical solutions.
YTD Price Performance: -31.83%
Average Trading Volume: 4,406
Technical Sentiment Signal: Buy
Current Market Cap: $492.1M
See more data about PNV stock on TipRanks’ Stock Analysis page.